Загрузка...
Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
Choosing antithrombotic regimens for patients with atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) with stent placement is challenging. Until recently, the guidelines recommended warfarin-based triple therapy, which causes frequent major bleeding events in up to 12% o...
Сохранить в:
| Опубликовано в: : | J Lipid Atheroscler |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society of Lipidology and Atherosclerosis
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7379079/ https://ncbi.nlm.nih.gov/pubmed/32821695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12997/jla.2019.8.1.8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|